Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma Life Science Investing
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum Medical Device Investing
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 Life Science Investing
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer Life Science Investing
Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients Life Science Investing
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance Life Science Investing
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates Medical Device Investing
